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Abstract. 
 
The type I epidermal keratins K14 and K16 
are remarkably similar at the primary sequence level. 
While a structural function has been clearly deﬁned for 
K14, we have proposed that a function of K16 may be 
to play a role in the process of keratinocyte activation 
that occurs after acute injury to stratiﬁed epithelia. To 
compare directly the functions of the two keratins we 
have targeted the expression of the human K16 cDNA 
to the progenitor basal layer of the epidermis of K14 
null mice. Mice null for K14 blister extensively and die 
 
z
 
2 d after birth (Lloyd, C., Q.C. Yu, J. Cheng, K. Turk-
 
sen, L. Degenstein, E. Hutton, and E. Fuchs. 1995. 
 
J. 
Cell Biol.
 
 129:1329–1344). The skin of mice expressing 
K16 in the absence of K14 developed normally without 
evidence of blistering. However, as the mice aged they 
featured extensive alopecia, chronic epidermal ulcers in 
areas of frequent physical contact, and alterations in 
other stratiﬁed epithelia. Mice expressing a control 
K16-C14 cDNA also rescue the blistering phenotype of 
the K14 null mice with only a small percentage exhibit-
ing minor alopecia. While K16 is capable of rescuing 
the blistering, phenotypic complementation in the re-
sulting skin is incomplete due to the multiple age de-
pendent anomalies. Despite their high sequence simi-
larity, K16 and K14 are not functionally equivalent in 
the epidermis and other stratiﬁed epithelia and it is pri-
marily the carboxy-terminal 
 
z
 
105 amino acids of K16 
that deﬁne these differences.
Key words: epidermis • hair • keratin • transgenic 
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 complexity of skin epithelia is reflected by the
large number of keratin genes expressed in these
tissues. Of the 
 
.
 
40 cloned keratin genes, at least 11
can be expressed in the epidermis alone including the type
II keratins K1, K2e, K5, and K6, and the type I keratins
K9, K10, K14, K15, K16, K17, and K19. The dividing basal
cells of the epidermis synthesize K5, K14 (36), and low
amounts of K15 (25). In addition, a small subset of basal
cells express K19 (33, 44). As a basal cell stops dividing
and begins the process of terminal differentiation that ulti-
mately results in squame production, K5 and K14 gene ex-
pression is halted while K1 and K10 synthesis begins (12).
These suprabasal keratinocytes also synthesize K2e as
they proceed along the differentiation pathway (4). The
genes for K6, K16, and K17 are not expressed in the nor-
mal interfollicular epidermis, but are expressed in a patchy
fashion in palmar and plantar epidermis. In addition, these
keratins are expressed in the outer root sheath of the hair
follicle and in several epithelia of the oral mucosa and up-
per digestive tract including the tongue, gingiva, esopha-
gus, and forestomach (30, 35, 38).
Keratin function in the epidermis has been clearly eluci-
dated by numerous transgenic mouse studies. Expression
of dominant negative mutant keratin proteins (9, 13, 42,
47, 63) or the absence of a keratin (25) resulted in fragile
epidermides that were susceptible to blistering. In addi-
tion, several human blistering genodermatoses including
epidermolysis bullosa simplex (K5 and K14), epidermo-
lytic hyperkeratosis (K1 and K10), ichthyosis bullosa of
Siemens (K2e), and palmoplantar keratoderma (K9) have
been found to be caused by dominant negative mutations
affecting specific keratin genes (7, 19, 31). Mutations that
result in tissue blistering have also been found in the ker-
atins expressed in the oral mucosa (K4, K13) and the cor-
nea (K3, K12) (17, 45, 50). Clearly, a general function of
keratins is to provide mechanical support in the various
complex epithelia. Whether keratins perform additional
functions in complex epithelia is unknown at the present
time. However, studies in simple epithelia, such as liver,
strongly suggest a distinct role for simple epithelial ker-
atins during metabolic stress (21).
Inherited mutations in the coding sequences of K6, K16,
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and K17 result in the diseases Pachyonychia Congenita (2,
32), nonepidermolytic palmoplantar keratoderma (K16),
and steatocystoma multiplex (K17; references 53, 54).
However, K16 mutations do not result in keratinocyte cy-
tolysis, which is surprising since comparable mutations in
the previously mentioned epidermal keratins do (7, 31).
K6, K16, and K17 are noted for their rapid induction in su-
prabasal keratinocytes at the wound edge following injury
to skin (28, 40, 61). This induction occurs as early as 
 
z
 
6 h
after injury (28, 30, 40, 59). The expression of these ker-
atins along with other major changes in gene expression
that occur during a 
 
z
 
16–24-h period, termed the activa-
tion phase (6, 14), precedes migration into the wound site.
The activated keratinocytes increase in size and their kera-
tin filaments fragment and relocate adjacent to the nu-
cleus. In addition, the intercellular space between them in-
creases along with changes in the number and structure of
desmosomes. K6, K16, and K17 are also expressed in strat-
ified epithelia undergoing abnormal differentiation or hy-
perproliferation, including psoriasis and cancer (30, 55,
66). K6 and especially K17 are also prominently expressed
during prenatal skin development (29). Expression of
these keratins, therefore, is associated with very plastic
states of a keratinocyte.
We have presented evidence that K16 may play a role in
the process of keratinocyte activation. Initial experiments
revealed that K16 formed relatively short filaments that
were preferentially located adjacent to the nuclei of cells
(40). The expression of K16 in cultured epithelial cells or
in the suprabasal keratinocytes of transgenic mouse epi-
dermis caused a relocalization of the endogenous keratins
resulting in perinuclear aggregation (40, 58). An addi-
tional transgenic mouse study, in which K16 was expressed
in the basal layer of the epidermis, also resulted in the
bundling and relocalization of keratin filaments along with
decreases in cell-cell adhesion (39). The morphologies ob-
served in all of these keratinocytes are strikingly similar to
that of the activated keratinocyte. Ectopic expression of
K16 in the basal layer also resulted in the delayed matura-
tion of mouse skin which was strikingly similar to what oc-
curs when the EGF receptor is activated in skin (39). This
potential involvement of K16 with signaling and cyto-
architectural modulation strongly argues that there are
other functions for keratins in addition to providing me-
chanical support.
The inactivation of the mouse K14 gene resulted in
basal keratinocytes that lacked a substantial keratin fila-
ment network and exhibited severe cytolysis due to their
inability to withstand mechanical trauma (25). A clear
structural function for K14 in the epidermis was estab-
lished as this severe, EBS-like phenotype resulted in the
death of the K14 null mice generally 
 
z
 
2 d after birth (25).
This genetic alteration has provided a unique opportunity
in which to test the functional significance of keratin se-
quence diversity. Our objective has been to express human
K16 in the basal layer of these mice to determine if the le-
thal phenotype of these mice can be complemented by an-
other epidermal keratin. Transgenic mice ectopically ex-
pressing K16 in the basal layer of mouse epidermis (39)
were mated with the K14 null animals to generate the K16
replacement mice. In addition, as a control, replacement
mice were generated that expressed a K16-C14 chimeric
 
protein that behaves functionally as K14 in various assays
(39, 40, 65). While both types of replacement mice rescue
the early blistering phenotype, we report here that there
are dramatic differences between the two that further ac-
centuate the unique nature of K16.
 
Materials and Methods
 
Generation of the Replacement Mice
 
All protocols involving mice were approved by the Johns Hopkins Uni-
versity Animal Care and Use Committee (Baltimore, MD). Transgenic
mice expressing either the K16 cDNA or the K16-C14 cDNA under the
control of the human K14 promoter have been previously described (39).
In short, the cDNAs were subcloned into a modified version of the K14
cassette expression vector which contains 2 kb of human K14 promoter se-
quence, the rabbit 
 
b
 
-globin intron, and 0.6 kb of human K14 poly A se-
quence (52). The purified constructs were micro-injected into fertilized
C57B6/BalbC3 F
 
2 
 
mouse embryos. K14 null mice were generated in the
129/SV background as previously described (25). Two K16-C14 and four
K16 transgenic lines were generated with each having a single insertion
site. The approximate transgene copy number for the K16 lines ranged
from 
 
z
 
10 (no. 13 line), to 
 
z
 
15 (no. 6 and no. 10 line), to 
 
z
 
45 (no. 21 line).
To generate the replacement mice, mice heterozygous at the insertion site
for the transgene were mated with mice that were heterozygous for the
K14-targeted (null) allele (25). Offspring were screened for the presence
of the transgene and the K14-targeting event by Southern blotting as pre-
viously described (25, 39). The desired mice were then bred until the re-
placement offspring were obtained.
 
Northern Blot Analysis
 
To determine the levels of transgene mRNA in the various mice, total
RNA was isolated from the skin of 7-d-old mice. Skin obtained from
killed animals (
 
z
 
250 mg) was frozen in liquid nitrogen and crushed using
a mortal and pestle kept cold with dry ice. The pulverized pieces were ho-
mogenized in 2 ml of Trizol reagent (GIBCO BRL) and the total RNA
was isolated according to the manufacturer’s protocol. Equivalent
amounts of isolated RNA (30–40 
 
m
 
g) were electrophoresed using a 1%
agarose gel containing formaldehyde and transferred to a nylon mem-
brane (NEN Life Science Products). Membranes were prehybridized for
30 min at 65
 
8
 
C in hybridization buffer (50 mM Tris, pH 7.4, 1 M NaCl, 1%
SDS, and 10% PEG 8000). Hybridization was carried out overnight at
65
 
8
 
C. Blots were washed for 20 min at 65
 
8
 
C four times with 0.1
 
3
 
 SSC,
0.5% SDS. A 500-bp HindIII-BamHI fragment from the K14 cassette (51)
was used as a probe to specifically detect the human transgene mRNAs
(K16 or K16-C14 mRNA). An 
 
z
 
140-bp FspI-HindIII fragment from a
plasmid containing the mouse K14 cDNA (18) was used to detect mouse
K14. Mouse actin was detected using a probe derived from DNA from
Ambion.
 
Western Blot Analysis
 
Urea soluble proteins were isolated from dorsal skin of killed animals as
previously described (39). Equivalent amounts of isolated proteins (
 
z
 
20
 
m
 
g, as determined by spectrophotometry and confirmed by Coomassie
blue staining) were resolved via 8.5% SDS-PAGE and transferred to ni-
trocellulose. Western blotting was performed using the alkaline phos-
phatase method (Bio-Rad Laboratories). Human K16 was detected using
the previously described rabbit polyclonal no. 1275 (58). Mouse K16 was
specifically detected using RPmK16, a rabbit polyclonal antibody (43).
Mouse K14 and human K16-C14 were detected with the mouse mono-
clonal antibody LL001 (44) that recognizes an identical sequence shared
between the human and mouse K14 tail domains. Mouse K5 was detected
using the rabbit polyclonal antibody no. 5054 (24) while K6 was detected
using the rabbit polyclonal K6 general antibody (29). K17 was detected with
the rabbit polyclonal 
 
a
 
-K17 antibody (29) and K15 was detected with the
rabbit polyclonal antibody UC54 (25).
For the solubility experiments, skin from killed animals was crushed as
previously described and homogenized in a buffer containing 1% Triton
X-100 in PBS and 5 mM EDTA. After centrifugation, the supernatant was
isolated (soluble fraction) and the pellet was homogenized in HSE buffer
(26). After another centrifugation, the insoluble pellet was homogenized 
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in buffer A (39). This urea soluble fraction is referred to as the insoluble
fraction.
 
Culture and Analysis of Primary Mouse Keratinocytes
 
Primary cultures of skin keratinocytes were established as previously de-
scribed (39, 48). 1–4 d after plating, the primary keratinocytes were pro-
cessed for immunofluorescence. The coverslips were washed three times
in PBS and fixed for 15 min with 100% methanol at 
 
2
 
20
 
8
 
C. After three
washes with PBS, coverslips were blocked with 5% normal goat serum in
PBS. Primary antibodies were diluted in blocking buffer and incubated for
45 min at room temperature. FITC-conjugated goat anti–mouse and rab-
bit, rhodamine-conjugated goat anti–mouse and rabbit, and FITC-conju-
gated goat anti–guinea pig secondary antibodies were used to detect
bound primary antibodies. Coverslips were mounted onto slides and ana-
lyzed via fluorescence microscopy. Primary antibodies used were mouse
monoclonals LL001, LL025 (anti-K16; reference 23), K8.60 (anti-K10;
Sigma Chemical Co.), K8.12 (anti-K16; Sigma Chemical Co.), and rabbit
polyclonals no. 1275, K6 general, 
 
a
 
-K17, and no. 5054.
 
Morphological Analyses
 
Mouse tissues were fixed in Bouin’s overnight at 4
 
8
 
C. The fixed tissues
were embedded in paraffin and 5-
 
m
 
m sections were stained with hematox-
ylin and eosin or immunostained using the horseradish peroxidase proce-
dure (HRP) by following the manufacturer’s protocol (Kirkegaard and
Perry Labs.). Primary antibodies used were mouse monoclonals LL001
and K8.60, and rabbit polyclonals no. 1275, K6 general, and 
 
a
 
-K17. For
electron microscopy, dorsal and ventral skin tissues were fixed with 2.5%
glutaraldehyde in 0.1 M sodium cacodylate, post-fixed in aqueous 1% os-
mium tetroxide, and embedded in LX112 epoxy-resin (Ladd Research In-
dustries Inc.). Ultrathin sections (50–70 nm) were placed on copper grids,
counterstained with uranyl acetate and lead citrate, and visualized using a
Zeiss EM10 transmission electron microscope operated at 60 kV.
 
Skin Challenges
 
Mice were anesthesized with avertin and their backs were depilated with
Nair (Carter-Wallace). PMA treatment (phorbol-12-myristate-13-ace-
tate; Sigma Chemical Co.) was performed by topically applying 200 
 
m
 
l (50
 
m
 
m stock in acetone) on days 1, 3, 5, and 7 (56). The tissue was harvested
for analysis on day 7. Two methods were employed to test the mechanical
integrity of back skin. Scotch Guard tape (3M) was repeatedly applied
(
 
z
 
20 times) to back skin and removed with a sudden motion. The stratum
corneum could be seen attached to the tape. Alternatively, depilated back
skin was vigorously rubbed using a thumb and forefinger for 30 s. This
was repeated every other day (days 1, 3, 5, and 7) over the course of a
week. It was also performed right before the tissue was harvested for anal-
ysis (day 7).
 
Results
 
Generation of the Replacement Mice
 
The four previously described K16 ectopic transgenic
lines, no. 6, 10, 13, and 21 and the two K16-C14 ectopic
transgenic lines, no. B1 and C1 in the C57B6/BalbC3 back-
ground (39) were bred with the 129/SV K14 null mice (25)
to generate the K16 and K16-C14 replacement mice. Mice
heterozygous for the K16 or K16-C14 transgene (Tg
 
1
 
/
 
2
 
)
were mated with mice that were hemizygous null at the
K14 locus (K14
 
1
 
/
 
2
 
). The desired F1 offspring (Tg
 
1
 
/
 
2
 
,
K14
 
1
 
/
 
2
 
) were mated with each other to generate the re-
placement mice. While a total of nine different F2 geno-
types are possible from this mating, the three of interest
were: (a) K14 null mice (Tg
 
2
 
/
 
2
 
, K14
 
2
 
/
 
2
 
); (b) heterozy-
gous replacement mice (Tg
 
1
 
/
 
2
 
, K14
 
2
 
/
 
2
 
); and (c) ho-
mozygous replacement mice (Tg
 
1
 
/
 
1
 
, K14
 
2
 
/
 
2
 
). In addi-
tion, wild-type mice (Tg
 
2
 
/
 
2
 
, K14
 
1
 
/
 
2
 
, or K14
 
1
 
/
 
1
 
) were
included as controls.
The K14 null mice develop gross blistering over their
 
body surface and die 
 
z
 
2 d after birth (25). Thus, this ge-
netic background provides a clear readout for epidermal
keratin function in the skin. All four of the K16 replace-
ment lines and the two K16-C14 replacement lines were
able to rescue the young mice from death. In addition, ei-
ther replacement genotype (Tg
 
1
 
/
 
2
 
 or Tg
 
1
 
/
 
1
 
, K14
 
2
 
/
 
2
 
)
rescued the K14 null phenotype. No replacement mice dis-
played skin blistering at any body site at an early age.
 
Young Replacement Mice Have Normal Skin
 
The hyperproliferative phenotype of the K16 ectopic mice
is most severe 
 
z
 
7 d after birth (39). To determine if there
were any comparable morphological or molecular aberra-
tions at the same age in the replacement mice, trunk skin
from 7-d-old K16 and K16-C14 replacement mice was ex-
amined by light microscopy (Fig. 1, A and B). Skin tissue
sections were analyzed by hematoxylin and eosin staining
or by immunohistochemistry. The skin of both types of re-
placement mice appeared equivalent and normal com-
pared with wild-type skin (Fig. 1, A and B, data not
shown). In both cases, there were abundant hair follicles
correctly oriented in the hypodermis and the epidermides
were of normal thickness. No aberrations could be ob-
served in any layers of the epidermis in either type of re-
placement mouse. In addition, there was no evidence of
blistering in the basal layer.
The localization of the transgenic proteins was deter-
mined by performing immunohistochemical analysis with
tail domain specific antibodies. Both transgenes were de-
tected in the outer root sheath of hair follicles and in the
basal layer of the epidermis (Fig. 1, C and F). There was
no signal corresponding to K14 in the K16 replacement
sample (Fig. 1 E) and there was no signal corresponding to
K16 in the K16-C14 replacement sample (Fig. 1 D) as ex-
pected. Based on these data, the transgenes were correctly
expressed in a K14-like fashion (39, 62).
K10 was used as a marker to determine if early terminal
differentiation was normal in the replacement mice (Fig.
1, G and H). Both samples featured suprabasal staining of
the epidermis using the K8.60 antibody, which was identi-
cal to a wild-type sample (data not shown). Filaggrin
staining was also performed to determine if there were
any differences in late terminal differentiation in the re-
placement mice. No differences were noted when com-
pared with the wild-type sample (data not shown). Ker-
atins K6 and K17, which are commonly associated with
hyperproliferation or altered differentiation in skin (55,
57, 66) were also analyzed. The expression of both was re-
stricted to the outer root sheath of the hair follicles in
both cases (data not shown). In addition, BrdU labeling
indicated no differences in the number of mitotic nuclei
between the two replacement samples and a wild-type
sample (data not shown). Based on these multiple crite-
ria, the skin appears to develop and self-renew normally
in both types of replacement mice at an early age. These
results are in stark contrast to those observed in the K16
ectopic mice that featured multiple hyperproliferative ab-
normalities and aberrant keratin expression in the skin at
 
z
 
7 d (39), suggesting that the keratin composition of a
keratinocyte is crucial in determining the effects of K16 in
the skin. 
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Electron Microscopy of Young Replacement Epidermis
 
To finely assess whether young replacement epidermis
was truly similar to wild-type epidermis, ventral skin from
7-d-old wild-type and K16 replacement mice was exam-
ined by transmission electron microscopy. There were no
discernible morphological differences between replace-
ment and wild-type basal keratinocytes. K16 replacement
Figure 1. Light microscopy analysis
and transgene expression in replace-
ment skin. 7-d-old trunk skin was fixed,
embedded in paraffin, and 5-mm sec-
tions were stained with hematoxylin
and eosin (H & E) or subjected to im-
munohistochemistry using the HRP
procedure. H & E staining of K16 (A)
and K16-C14 (B) replacement skin.
Both epidermides featured a normal
cellular morphology along with multi-
ple anagen staged hair follicles. There
were no detectable differences when
compared with wild-type 7-d-old epi-
dermis (data not shown). (C–F) Trans-
gene detection. The K16 transgene
protein was detected using the 1275 an-
tibody (C) and was restricted to the
basal layer of the epidermis and the
outer root sheath of the hair follicle.
The K16-C14 transgene protein was
detected (F) using the LL001 antibody
and showed the same distribution.
There was no detection of K16 in the
K16-C14 replacement sample (D) and
there was no detection of K14 in the
K16 replacement sample (E). (G and
H) Both samples were also stained with
an antibody against K10. K10 expres-
sion was detected throughout the su-
prabasal layers of the epidermis in both
the K16 (G) and K16-C14 (H) samples
indicating that there is no evidence of
abnormal differentiation. Hf, hair fol-
licle. Arrowheads, demarcate the
dermal-epidermal junction. Asterisks,
melanin granules in hair follicle pro-
files. Bar, 100 mm. 
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basal keratinocytes (Fig. 2 B) had a low-columnar, cuboi-
dal shape and were tightly packed together. There were no
obvious alterations in cell-cell or cell-matrix adhesion.
Keratin filaments were loosely bundles and distributed
throughout the cytoplasm. These same morphological
characteristics were observed in both wild-type (Fig. 2 A)
and K16-C14 replacement basal keratinocytes (data not
shown). There was also no evidence of cell lysis or epider-
mal blistering. Spinous keratinocytes in the replacement
epidermis (K16 or K16-C14) were also normal. Filament
bundling occurred with the concomitant increase in the
number of desmosomes (data not shown). Cells in the
granular layer and the stratum corneum of replacement
epidermis were also similar to wild-type (data not shown).
By all morphological criteria, the replacement epider-
mides are equivalent to wild-type epidermis. This is in
stark contrast to what was observed in the basal kerati-
nocytes from ectopic K16 phenotypic epidermis in which
the hypertrophic basal keratinocytes had large aggrega-
tions of keratin filaments and major decreases in cell-cell
adhesion (39).
 
K16 Replacement Keratinocytes Have Aberrant Keratin 
Filament Networks in Culture
 
The electron microscopy results prompted the examina-
tion of the replacement keratinocytes in culture in order to
analyze the global organization of the keratin filaments
within the context of an intact keratinocyte. Primary cul-
tures of newborn keratinocytes from K16 and K16-C14 re-
placement mice were established and analyzed by immu-
nofluorescence to further determine if there were any
possible abnormalities in the keratin networks of the K16
replacement mice. K16 replacement keratinocytes ap-
peared normal after one day in culture (data not shown).
All cells were positive for K5, K6, human K16, and K17,
and negative for K14 (data not shown). As the cells re-
mained in culture, however, they began to display time-
dependent changes in their keratin filament networks. In a
subset of cells (
 
,
 
50%), the keratin filament networks be-
gan to appear fragmented and even absent in some areas
of the cytoplasm (Fig. 3, B and C). There were also large
bundles of filaments that were distributed throughout the
cell (Fig. 3 A) rather than preferentially located adjacent
to the nucleus as previously noted for the K16 ectopic ke-
ratinocytes (39). There was no evidence of keratin reorga-
nization, fragmentation, or loss in any of the K16-C14 re-
placement keratinocytes regardless of the time spent in
culture. These keratinocytes featured filament networks
that were indistinguishable from wild-type keratinocytes
(Fig. 3 D). These data suggest that in the absence of K14,
K16 is not able to support a keratin filament network and
that over time this fragile network is susceptible to frag-
mentation and loss. Furthermore, they provide further evi-
dence that the carboxy-terminal 
 
z
 
105 amino acids of K16
are responsible for these differences in filament organiza-
tion.
 
Transgene Expression in the Epidermis
 
We have previously shown that the expression of K16 pro-
tein at levels comparable to endogenous mouse K14 was
able to cause the hyperproliferative skin phenotype of the
K16 ectopic mice (39). The lack of a phenotype in the re-
placement mice at an early age raised the possibility that
transgene expression was reduced in these mice. To test
this idea, urea extractable proteins were isolated from the
back skin of 7-d-old heterozygous and homozygous re-
placement mice from the no. 10 line and compared with
wild-type, heterozygous, and homozygous ectopic mice
from the same line (no. 10) by Western blot analysis (Fig.
4 A) using the no. 1275 antibody which specifically reacts
Figure 2. Transmission elec-
tron microscopy of wild-type
and replacement mouse epi-
dermis. Ventral skin was iso-
lated from 7-d-old wild-type
and K16 replacement mice
and processed for electron
microscopy. (A and B) Basal
cells from wild-type (A) and
K16 replacement epidermis
(B). K16 replacement basal
keratinocytes (B) are mor-
phologically similar to wild-
type keratinocytes (A). Both
feature bundles of filaments
(kf) distributed throughout
the cytoplasm and multiple des-
mosomal (small arrowheads)
and hemidesmosomal (arrows)
attachments. There is no evi-
dence of decreased cell-cell
adhesion or blistering in any
layers of the epidermis. Large
arrowheads, the basal lamina.
Nu, nucleus; m, mitochon-
dria. Bar: (A and B) 2 mm. 
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Figure 3. Immunofluorescence analysis of keratins in cultured primary keratinocytes from replacement mice. Keratinocytes were iso-
lated from the epidermides of newborn K16 and K16-C14 replacement mice, cultured, and analyzed by indirect double immunofluores-
cence to examine the keratin filament networks. Keratinocytes from K16 replacement mice (A–C) were stained with the 1275 antibody
to detect K16. Some K16 replacement keratinocytes had fragmented keratin networks and cytoplasmic areas devoid of filaments (B and
C). Others exhibited large bundling of filaments randomly distributed throughout the cytoplasm (A). Keratinocytes from K16-C14 re-
placement mice (D) were stained with the LL001 antibody to detect K16-C14. These keratinocytes appeared identical to wild-type kera-
tinocytes (data not shown) in all morphological aspects as there was no evidence of keratin reorganization, fragmentation, or loss. Bar,
25 mm.
 
with the tail of human K16 and exhibits partial cross-reac-
tivity with mouse K16 (8, 30). As previously documented,
the amount of K16 transgene expressed in the homozy-
gous ectopic mouse sample was approximately twice the
amount expressed in the heterozygous ectopic sample
(39). Interestingly, there was no difference in transgene
expression between the heterozygous and homozygous re-
placement mice. Furthermore, the level of transgene ex-
pression was lower than that observed in the homozygous
ectopic sample but higher than the heterozygous ectopic
sample. This possible difference between the replacement
and the homozygous ectopic samples may be accounted
for by cross-reactivity of the 1275 antibody with mouse
K16, which is induced in the homozygous ectopic sample
(see below, Fig. 4 E).
The same type of Western blot analysis was performed
with mice from the K16-C14 no. B1 ectopic and replace-
ment lines using the LL001 antibody which detects the
K14 moiety of the chimera (Fig. 4 B). As was the case with
the K16 transgenics, the amount of K16-C14 approxi-
mately doubled from the heterozygous ectopic sample to
the homozygous ectopic sample (the upper band in these
and the control sample is endogenous mouse K14). The
level of transgene expression was similar between the het-
erozygous and homozygous samples also. However, in
contrast to the results observed in the no. 10 line, the
amount of transgene expressed in the replacement back-
ground was greater than in the homozygous ectopic
sample.
Further Western blot analysis of urea extractable pro-
teins from 7-d-old trunk skin from the four K16 replace-
ment lines was performed to determine if there were dif-
ferences in transgene expression between the various
replacement lines or between the two types of replacement
genotypes (Tg
 
1
 
/
 
2
 
 and Tg
 
1
 
/
 
1
 
). Equivalent amounts of
protein from both heterozygous and homozygous replace-
ment mice from each of the four K16 lines were analyzed
using rabbit polyclonal antibody no. 1275. As was the case
with the no. 10 line (Fig. 4 A), the amount of transgene ex-
pression was the same within a given line regardless of the
genotype (Fig. 4 C). However, the level of expression var-
ied slightly between the lines. Compared with the ectopic 
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mice, the maximal K16 transgene levels are slightly re-
duced in the replacement background with the exception
of the no. 13 line in which the levels are increased (data
not shown). Thus, in the K14 null background there ap-
pears to be a tightly regulated range of transgene protein
levels allowed in a keratinocyte which may be modulated
by the levels of K5 and possibly K6 (59). Collectively these
data strongly suggest that K14 has a dramatic impact on
the regulation of K16 (or K16-C14) in a keratinocyte.
The fact that K14 has an impact on K16 levels prompted
the mating of the two types of replacement mice to gener-
ate double replacement mice that express both transgenes.
Urea extractable proteins from 7-d-old double replace-
ment trunk skin was analyzed by Western blot analysis to
determine if the two transgenes could influence the ex-
pression levels of each other. Proteins from K16, K16/K16-
C14, and K16-C14 replacement mice were probed with the
1275 or the LL001 antibody to detect the transgenes. The
levels of both K16 and K16-C14 in the double replacement
sample were equivalent to the amount produced in the sin-
gle replacement samples (Fig. 4 D). Although the chimeric
transgene contains the last 
 
z
 
105 amino acids of K14, it
was not able to affect the levels of K16 transgene expres-
sion.
In addition to transgene expression, the levels of other
epidermal keratins were examined by Western blot analy-
sis to determine if there were any differences in keratin ex-
pression that may account for the phenotypic differences
observed between the ectopic and replacement mice at 7
days of age. Equivalent amounts of urea proteins from
trunk skin of various ectopic and replacement samples
were probed with specific antibodies against K5, K6, K15,
mouse K16, and K17 (Fig. 4 E). K5 levels were equivalent
in all samples except in the homozygous ectopic and dou-
ble replacement where the amount of K5 was slightly in-
creased. K6 and mouse K16 levels were equal in all mice
except for the homozygous ectopic sample where both
were greatly increased. This is consistent with the fact that
the epidermis of these mice is hyperproliferative and that
K6 staining was observed in the suprabasal layers of these
mice (39). While K17 levels were equivalent among all
samples, K15 was dramatically reduced in the homozygous
ectopic sample. K15 is expressed in a pattern analogous to
K14 in the epidermis but at much lower levels (25). It is in-
Figure 4. Analysis of trans-
gene and keratin expression
in the skin. Urea-soluble pro-
tein extracts were obtained
from the skin of various 7-d-old
replacement and ectopic mice
from the K16 lines no. 6, no.
10, no. 13, and no. 21, and
the K16-C14 line no. B1.
Equivalent amounts of pro-
teins (z20 mg) were electro-
phoresed via SDS-PAGE and
transferred to nitrocellulose
for Western blot analysis. (A
and B) Comparing K16 and
K16-C14 expression in the
replacement vs. ectopic back-
ground. A wild-type, heterozy-
gous transgenic, homozygous
transgenic, heterozygous re-
placement, and homozygous
replacement samples from a
K16 (no. 10) and a K16-C14
line (no. B1) were analyzed
by Western blot analysis and
probed with either the no.
1275 antibody to detect K16
(A) or with the LL001 anti-
body to detect the K14 moiety
of the chimera (B). The
amount of K16 transgene ex-
pressed in the heterozygous
and homozygous replacement samples were equivalent and slightly less than that expressed in the homozygous ectopic sample (A). In
contrast, K16-C14 expression was increased in the replacement background compared with the ectopic background and the amount was
equivalent independent of the replacement genotype. (C) Determination of the amount of K16 expression in the four replacement
lines. Equivalent amounts of K16 were detected regardless of the genotype within each line. (D) Determination of transgene expression
in the double replacement mice. The amount of K16 and K16-C14 expressed in the double replacement was similar to the amount made
in either of the individual replacement mice. (E) Antibodies against K5, K6, K15, mouse K16, and K17 were used to determine keratin
levels in the skin of various mice. K5 levels were slightly increased in the homozygous ectopic and double replacement samples. K6 and
mouse K16 were greatly increased in the homozygous ectopic sample as expected due to the hyperproliferative epidermis of these mice
(39). While K17 levels were equivalent in all mice, K15 was greatly reduced in the homozygous ectopic sample. 
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teresting to note that a type I keratin that is such a minor
component of basal cells is decreased to such levels while
K14 levels remain unchanged (39). It has recently been re-
ported that K15 mRNA levels in hyperproliferative hu-
man skin are decreased (64). These results suggest that the
keratin profiles of the replacement samples are very simi-
lar to control and nonphenotypic, heterozygous ectopic
samples for those keratins examined.
 
Transgene mRNA Expression in the Ectopic and 
Replacement Mice
 
We performed Northern blot analysis on total RNA iso-
lated from 7-d-old ectopic and replacement mouse skin to
determine if the protein levels were an accurate reflection
of the steady state levels of transgene mRNA. Equivalent
amounts of total RNA were analyzed using a transgene
specific probe that detects both the K16 and K16-C14 mes-
sages but does not cross react with nontransgenic control
RNA (Fig. 5). The heterozygous ectopic no. 10 sample fea-
tured one band that reacted strongly with the transgene
probe. The intensity of the K16 transgene in the no. 10 ho-
mozygous ectopic sample was increased at least fourfold
compared with the heterozygous sample which is not con-
sistent with the protein results. However, when the same
samples were analyzed using a probe specific for mouse
K14 the amount of this message was also increased in the
homozygous sample (Fig. 5). These findings were repro-
ducible as other comparable sets of samples from the no.
10 and no. 21 lines yielded similar results. This is consis-
tent with a previous report that showed that the activity
of the K14 promoter increases during hyperproliferation
(42). In addition, the mRNA levels of K6 and mouse K16
are elevated only in the ectopic homozygous samples (data
not shown). Thus, the human K14 promoter that drives
transgene expression is stimulated in the homozygous ec-
topic sample because of the hyperproliferative conditions
prevalent at 7 days of age.
The steady state level of K16 transgene mRNA in the
homozygous replacement no. 10 sample was lower than
that observed in the two no. 10 ectopic samples despite the
fact that the amount of K16 protein in the no. 10 replace-
ment line is intermediate between the two heterozygous
ectopic samples (Fig. 4 A). The level of transgene mRNA
from a homozygous replacement no. 21 sample was much
greater compared with the no. 10 replacement sample.
However, the amount of transgene protein expressed in
skin is essentially equivalent for the two lines (Fig. 4 C)
suggesting that despite the wide range in steady state
transgene mRNA levels between the lines there is a limit
to the amount of K16 protein that can be expressed in a re-
placement basal keratinocyte.
In the no. B1 chimera line, there was more transgene
mRNA in the homozygous ectopic sample than in the
heterozygous replacement sample (Fig. 5) despite the
protein levels being higher in the heterozygous replace-
ment sample (see Fig. 4 B). These results provide further
evidence that the presence of K14 protein in the skin is
acutely critical in determining the levels of transgene pro-
tein expression and that the mechanisms responsible may
occur at both the transcriptional and post-transcriptional
levels.
 
Keratin Solubility in the Epidermis
 
We have previously shown that a single proline residue in
the 1B rod domain of human K16 (residue 188) com-
pletely accounts for the reduced stability of K16-contain-
ing heterotetramers under denaturing buffer conditions in
vitro (65). The reduced stability of these tetramers corre-
lated with the diminished ability of K16 to form 10-nm fil-
aments efficiently in vitro. This led to the possibility that
the solubility and partitioning of K16 between the soluble
and insoluble keratin pools in the epidermis may be an im-
portant factor in determining its effect on keratinocytes
(65). To determine if the partitioning of K16 was different
among the various types of mice, skin from 7-d-old mice
was lysed and the soluble and insoluble (cytoskeletal) frac-
tions were isolated and subjected to Western blot analysis
using various keratin antibodies (Fig. 6).
There was very little detectable human K16 protein in
the soluble fractions from any of the mice. The small
amount detectable was proportional to the amount ob-
served in the corresponding insoluble fractions. Thus,
there were no obvious differences in K16 solubility among
the samples. The same results were observed for mouse
K16, which does not contain a destabilizing proline resi-
Figure 5. Transgene mRNA expression in ectopic and replace-
ment mice. Total RNA was isolated from the skin of 7-d-old K16
and K16-C14 ectopic and replacement mice. z40 mg of each sam-
ple was electrophoresed in a formaldehyde containing gel and
subsequently transferred to a nylon membrane. A transgene spe-
cific probe was used to detect both the K16 and K16-C14 trans-
gene mRNAs. This probe did not react with any endogenous
mRNA (see control lane, data not shown). b-actin was used as a
probe to control for loading. Steady state levels of the K16 trans-
gene mRNA were more than doubled in the homozygous ectopic
sample compared with the heterozygous ectopic sample. This dis-
crepancy between the steady state mRNA levels and protein lev-
els may be partially accounted for by the increase in the activity
of the K14 promoter under hyperproliferative conditions (42) as
determined by the increase in mouse K14 mRNA in the homozy-
gous ectopic sample. K16 transgene mRNA varied widely in the
K16 replacement samples (no. 10 and no. 21 lines) despite the
fact that comparable amounts of protein was expressed in each
(see Fig. 4 C). K16-C14 mRNA levels were higher in the homozy-
gous ectopic sample than in the replacement sample despite the
fact that more protein is expressed in the replacement epidermis
(see Fig. 4 B). The same blot was used for all three probes. Rep.,
replacement. Ect., ectopic. 
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due in the 1B rod domain (McGowan, K., K. Hess, and
P.A. Coulombe, unpublished data, also see reference 43).
There were also no differences observed in the partition-
ing of K5, K6, and K17 (data not shown). The only differ-
ence observed was that more K15 appeared to be soluble
in the two replacement samples compared with the ectopic
samples. These results suggest that there are no major dif-
ferences in keratin solubility among the types of mice ana-
lyzed that could account for the phenotypic differences
observed and that the mechanism by which K16 functions
probably does not involve a change in its in vivo solubility.
 
Age-dependent Changes in the Skin and Other 
Stratified Epithelia
 
Beginning as early as 4–5 wk after birth, the K16 replace-
ment mice begin to lose hair (Fig. 7 A, middle mouse).
This alopecia generally initiates at the crown of the head
and proceeds in a head-to-tail fashion. The loss occurs pri-
marily on the dorsal surface but also occurs to a lesser ex-
tent on the ventral surface. Once lost, the hair does not re-
grow. While 
 
z
 
80% of the K16 replacement mice exhibit
alopecia, about one in three develop severe skin lesions
(Fig. 7 A, right mouse) characterized by epidermal ulcer-
ation and scar contraction. These lesions are more preva-
lent in areas of hair loss and frequent physical contact
(limbs, paws, eyes, nose, and mouth areas). Interestingly,
the amount of K16 transgene expressed in skin does not
change as a function of time. In fact, K16 transgene levels
from hairless or lesional skin from the 8-mo-old mice were
equivalent to the levels observed in 7-d-old skin (data not
shown).
These phenotypes occur in mice of either the heterozy-
gous or homozygous replacement genotype, which is ex-
pected given that transgene expression levels are equiva-
lent. In addition, the phenotypes observed occur in all four
of the K16 replacement lines. However, this phenotype is
not fully penetrant as 
 
z
 
20% of the K16 replacement mice
do not exhibit hair loss or skin lesions. This incomplete
penetrance may partially be due to the mixed genetic
background of the mice (see Materials and Methods). On
the other hand, only 
 
z
 
33% of the K16-C14 replacement
mice exhibit minor alopecia (Fig 7 B, right mouse) and
none have developed lesions.
As mentioned, a subset of the K16 replacement mice ex-
hibit hair loss and the development of skin ulcerations. To
understand these further, tissue samples from 8-mo-old
K16-C14 control and phenotypic K16 replacement mice
were taken from skin and a variety of other stratified epi-
thelia and examined by light microscopy. Nonphenotypic,
hairy skin from a K16 replacement mouse (Fig. 8 A) was
similar to wild-type and K16-C14 control skin (Fig. 8 E).
The epidermis was thin and there were many hair follicles.
However, the hair follicles were in the telogen stage as op-
posed to wild-type skin in which the follicles were in
anagen (data not shown). K16 transgene expression was
still restricted to the basal layer (data not shown). There
was no evidence of hyperproliferation as the epidermis did
not stain for K6 and K17 (data not shown).
In contrast, K16 replacement skin that exhibited hair
loss in the absence of any visible lesions was abnormal in
many respects (Fig. 8 B). The epidermis was significantly
thickened due to acanthosis and an increase in the number
of cell layers. While there were many anagen staged hair
follicles that extended deep into the hypodermis, some of
the follicles were misoriented and some were without hair
shafts (large asterisk in Fig. 8 B). In addition, there ap-
peared to be more sebaceous glands than in the wild-type.
K6 expression was observed in the suprabasal layers indic-
ative of hyperproliferation (data not shown).
Lesional K16 replacement skin also displayed many ab-
normalities (Fig. 8, C and D). The epidermis and the outer
root sheaths of the hair follicles were hyperplastic and
acanthotic. There was also strong K6 and K17 expression
in the suprabasal layers of the epidermis (data not shown).
Embedded in the dermis were many large cysts derived
from pilosebaceous units. Migration in the K16 replace-
ment epidermis was not inhibited as epithelial sheets ap-
peared to be migrating into an epidermal ulcer (Fig. 8 D).
The dermis also featured increased cellularity suggestive
of an ongoing inflammatory response. The hair follicles in
the lesional skin also extended very deeply into the hypo-
dermis.
While nonphenotypic hairy skin from a K16-C14 mouse
was normal in most morphological aspects (Fig. 8 E, see
above), skin from a hairless region (Fig. 8 F) displayed
many of the same abnormalities observed in the K16 re-
placement hairless skin (Fig. 8 B). The epidermis was
thickened and the hair follicles were anagen staged. There
appeared to be more sebaceous glands and there were also
Figure 6. Keratin solubility in the skin. Skins from
7-d-old ectopic and replacement mice (no. 6 line)
were homogenized in 1% Triton-X in PBS with 5
mM EDTA to obtain the soluble fraction of ker-
atins. The remaining insoluble cytoskeletal fraction
was solubilized in buffer A to obtain the insoluble
fraction of keratins. 100 mg of total protein from the
soluble fractions and 15 mg of total protein from the
insoluble fractions were electrophoresed via SDS-
PAGE, transferred to nitrocellulose, and analyzed
by Western blot analysis. Keratins analyzed in-
cluded K14, K15, mouse K16, and human K16. No
major differences were noted in the partitioning of
any of the keratins between the soluble and insolu-
ble fractions.The Journal of Cell Biology, Volume 146, 1999 1194
hair follicles that lacked hair shafts (large asterisk). There
was, however, no evidence of cyst formation.
In addition to skin, other stratified epithelia that feature
expression of the K16-C14 control and K16 transgenes in
the basal layer, including forestomach and cornea, were
examined. Forestomach from a K16 replacement mouse
(Fig. 8 H) exhibited extensive blistering and basal layer cy-
tolysis along the length of the tissue. On the other hand,
forestomach from a K16-C14 replacement mouse (Fig. 8
G) appeared completely normal when compared with
Figure 7. Age-dependent
phenotypic changes in the re-
placement mice. (A) Three
8-mo-old K16 replacement
littermates. The genotypes are
from left to right: K162/2,
K141/1 (wild-type), K161/1,
K142/2, and K161/2,
K142/2. Alopecia in these
mice can begin at z4–5
weeks of age and usually pro-
ceeds in a head-to-tail direc-
tion. The mouse on the right
has extensive epidermal ul-
cers. These ulcers usually oc-
cur in areas of hair loss and
frequent physical contact.
While  z80% of these mice
exhibit alopecia, approxi-
mately one in three develop
lesions. (B) Two 7-mo-old
K16-C14 replacement litter-
mates. The genotypes of
both mice are K16-C14 1/2,
K142/2. Alopecia occurs at
a much lower frequency
(z33%) in these mice and le-
sion formation has not been
noted.Paladini and Coulombe K16 Partially Complements the K14 Null Phenotype 1195
Figure 8. Light microscopy of various stratified epithelia from K16-C14 control and phenotypic K16 replacement mice. 5-mm paraffin
sections from 8-mo-old K16-C14 and K16 replacement mice were counterstained with hematoxylin and eosin (H & E). (A–D) Dorsal
skin sections from a K16 replacement mouse. Hairy skin (A) has a thin epidermis and telogen staged hair follicles. Skin from a hairless
region (B) features a thickened epidermis and an increase in the number of sebaceous glands. Some of the anagen staged hair follicles
are improperly oriented (large arrowhead) and are missing their hair shafts (large asterisk). Skin from lesional areas (C and D) has a hy-
perplastic epidermis, an expansion of the outer root sheath of the hair follicles, and a large dermal infiltrate suggestive of an inflamma-
tory response. There are also large cysts derived from pilosebaceous units (large asterisk). There are signs of migration of the epidermis
into ulcerated areas of the skin (arrows in D). Dorsal skin sections from a K16-C14 replacement mouse. Hairy skin (E) was morpholog-
ically similar to K16 replacement hairy skin (A). Hairless K16-C14 skin (F) also exhibited many of the same aberrations observed in the
K16 replacement hairless sample (B). There were also groups of melanocytes in the dermis not associated with hair follicles (arrows).
This was also observed in K16 hairless and lesional skin (data not shown). Forestomach epithelium from a K16-C14 control (G) and a
K16 replacement mouse (H). In the K16 replacement sample (H) there is extensive basal layer cytolysis along the length of the fore-
stomach (arrows), while the K16-C14 sample features a normal morphology (G). Cornea from a K16-C14 control (I) and a K16 replace-
ment mouse (J). The normal morphology and differentiation of the cornea is completely disrupted when compared with control (I) and
there is a large dermal infiltrate in the underlying connective tissue (J). hf, hair follicle; sg, sebaceous gland. Arrowheads, indicate the
junction between the stratified epithelium and the underlying connective tissue (A–D, the dermal-epidermal junction). Bar, 100 mm.The Journal of Cell Biology, Volume 146, 1999 1196
wild-type (data not shown). Some of the older K16 re-
placement mice had obvious corneal opacities (data not
shown). When corneal tissue from a K16 replacement
mouse (Fig. 8 J) with opacities was observed under the
light microscope, the normal morphology was completely
absent (compare with K16-C14 control cornea in Fig. 8 I).
The underlying connective tissue had a dramatic increase
in the cellularity, probably due to an inflammatory re-
sponse. It was also very difficult to discern basal, supra-
basal, and differentiating keratinocytes in the cornea.
These data clearly demonstrate that K16 expression in the
basal layer of various stratified epithelia in the absence of
K14 does not result in the normal differentiation and
maintenance of these tissues.
Morphological Changes in K16 Replacement
Hair Follicles
Hair follicles from K16 replacement and wild-type mice
were examined using transmission electron microscopy to
determine if there were ultrastructural changes that might
account for the hair loss observed. Outer root sheath kera-
tinocytes from the isthmus (permanent) portion of a telo-
gen staged wild-type hair follicle (Fig. 9 A) had a normal
morphology and the hair fiber stained darkly with OsO4,
uranyl acetate, and lead citrate, as expected for wild-type
hair (46). In contrast, anagen staged hair follicles from
hairless K16 replacement skin (Fig. 9, B and C) exhibited
severe vacuolization within the hair fiber which accounts
for the improper formation and absence of hair. In addi-
tion, the outer root sheath of the follicle had been invaded
by inflammatory cells (Fig. 9 B). There was also vacuoliza-
tion observed in the K16 replacement keratinocytes of the
outer root sheath. Hair follicles from hairless skin that did
not exhibit as severe vacuolization in the hair fiber (Fig. 9
D) still featured extensive vacuolization in the kerati-
nocytes of the outer root sheath. The vacuolization ob-
served in the keratinocytes of the outer root sheath may
be an event that precedes the improper formation of hair
observed in the hairless skin from K16 replacement mice.
Figure 9. Transmission elec-
tron microscopy of wild-type
and K16 replacement mouse
hair follicles. The isthmus
portion of hair follicles from
wild-type control skin (A)
and hairless K16 replacement
skin (B–D) was analyzed.
The outer root sheath of con-
trol follicles (A) has a normal
morphology and the cortex
stains darkly with OsO4, ura-
nyl acetate, and lead citrate,
as expected for wild-type hair
(46). In contrast to wild-type,
the cortex from a K16 re-
placement follicle (B) is
highly vacuolated (large as-
terisks). Vacuolization also
occurs in some cells of the
outer root sheath (small as-
terisks). Inflammatory cells
have also invaded the outer
root sheath (the two adjacent
cells in the center). Another
example (C) of the extreme
vacuolization observed in the
cortex of K16 replacement
follicles. Preceding the major
vacuolization observed in the
cortex is the appearance of
many keratinocytes in the
outer root sheath (D) that
are also vacuolated (small as-
terisks). Arrowheads, dermal-
epidermal junction. Nu, nu-
cleus. Bars: (A and B) 5 mm;
(C) 6.4 mm; (D) 8 mm.Paladini and Coulombe K16 Partially Complements the K14 Null Phenotype 1197
Challenging the Replacement Epidermis
The electron microscopy data from hairless K16 replace-
ment skin suggested that there were major morphological
alterations in the outer root sheath of the hair follicle, the
hair shaft, and in the correct cycling of the follicles. Hair-
less and hairy regions of K16 replacement skin were
treated with a depilatory agent to remove existing hairs
and to stimulate the anagen phase of the hair cycle (Fig. 10
A). Immediately after treatment the regions of skin that
were previously hairless had a much darker color com-
pared with the areas that were hairy (Fig. 10 B). As early
as 2 d after treatment there were signs of hair regrowth in
the region that was previously devoid of hair (data not
shown). Five days after treatment with the depilatory
agent hair regrowth was obvious in the previously hairless
region (Fig. 10 C) while hair regrowth had not occurred in
the previously hairy regions. After 2 wk (Fig. 10 D) the re-
grown hairs were quite long and hair growth in some of
the previously hairy regions had also occurred. Hair re-
growth in these regions was slower and more sporadic as
some of these areas remained hairless for many weeks af-
ter the treatment (data not shown). These results clearly
indicate that hair cycle progression and hair growth is ab-
errant in the K16 replacement mice.
Replacement skin was also subjected to mechanical
trauma to determine if the epidermis was weakening with
age. Skin from the three and 5-mo-old wild-type, K16, and
K16-C14 replacement mice was subjected to acute me-
chanical trauma by tape stripping of the epidermis or to
extensive mechanical trauma by vigorously rubbing the
skin between a thumb and forefinger over the course of a
week. Regardless of the treatment, there was no evidence
of blistering in any sample as analyzed by light microscopy
(data not shown). Despite the fact that alopecia and epi-
dermal ulcers occur, the K16 replacement skin is still resis-
tant to vigorous acute and prolonged mechanical trauma.
Replacement skin was treated with PMA, a phorbol es-
ter which stimulates hyperproliferation (56, and references
therein), to determine if there were changes in the prolif-
erative capacity of replacement basal keratinocytes as a
function of age. 3-mo-old wild-type, K16, and K16-C14
mice were treated with 50 mm PMA over the course of one
week (56). The epidermides of all three samples were dra-
matically thickened to a comparable extent after PMA
treatment and some spinous keratinocytes exhibited vacu-
olization (data not shown). However, there were no differ-
ences observed among the three samples. These data sug-
gest that the ability of replacement skin to respond to the
PMA treatment regimen applied is not compromised.
Discussion
K16 Does Not Fully Complement the K14 Null 
Phenotype: Implications for Keratin Sequence Diversity
The absence of K14 protein in the basal layer of mouse
epidermis results in a lethal phenotype that resembles epi-
dermolysis bullosa simplex (25). Neonatal mice exhibit se-
vere blistering over their body surface and generally die
early after birth. In the absence of K14, the residual kera-
tin filament network (K5/K15) is not able to provide suffi-
cient mechanical support to basal cells, which renders
them susceptible to trauma induced rupturing (3, 25, 49).
Thus, the integrity of basal cells in the epidermis is depen-
dent on the formation of a keratin filament network con-
taining K5 and K14. These results raise the question as to
whether basal cells specifically require K14 to achieve a
functional keratin filament network.
Figure 10. Hair regrowth in the K16 replacement mice. A K16 replacement mouse that featured dorsal alopecia was treated with a de-
pilatory agent to determine if hair regrowth could occur (A). Immediately after depilation, the hairless area had a darker color than the
surrounding skin (B). 5 d after treatment (C) hair regrowth in the previously hairless area was apparent while growth in the previously
hairy areas had not yet occurred. 2 wk after treatment (D) hair regrowth in both areas is obvious. Arrowhead, indicates the boundary
between the hairless and hairy skin areas.The Journal of Cell Biology, Volume 146, 1999 1198
Among the type I epidermal keratins, K14, K16, and
K17 share the highest amino acid identity. The identity be-
tween human K14 (472 amino acids) and K16 (473 amino
acids) is 91%-86%-38% along their tripartite head-rod-tail
domain structure (30, 60). Despite this high identity, they
are quite distinct in both their assembly properties (40)
and in their expression patterns (35, 66). Based on these
contrasting facts, we wanted to determine if K16 could
provide an equivalent function in the basal layer of mouse
epidermis and substitute for K14 by rescuing the lethal
blistering phenotype.
Expression of K16 in the basal layer of K14 null mice re-
sulted in the rescue of the lethal skin blistering phenotype.
The skin developed normally and there was no evidence of
blistering at an early age. As the mice aged they exhibited
extensive alopecia, developed chronic skin ulcerations in
areas of repeated physical contact, and displayed morpho-
logical alterations in other stratified epithelia. Compar-
atively, a small percentage of replacement mice that
expressed the K16-C14 chimeric protein exhibited only
minor alopecia. While no obvious abnormalities were ob-
served in the filament networks of replacement basal kera-
tinocytes in situ, transmission electron microscopy of ul-
tra-thin sections does not provide the optimal context in
which to evaluate their three dimensional organization. In
fact, when newborn K16 replacement keratinocytes were
placed in primary culture, multiple abnormalities in the or-
ganization of their keratin filament networks were ob-
served. Despite the fact that the K16 replacement skin is
susceptible to hair loss and epidermal ulcers in areas of
frequent trauma, and that an internal stratified epithelia
such as the forestomach featured blistering and cytolysis
of basal cells, we were unable to induce blistering in the
epidermis using a variety of methods. To provide mechan-
ical support to the tissue, keratinocytes from a particular
stratified epithelium may have different mechanisms of or-
ganizing keratin filaments. These results indicate that K16
can functionally substitute for K14 to a significant, yet in-
complete fashion, and that the carboxy-terminal z105
amino acids are responsible for a significant fraction of the
functional differences between these two keratins. These
features are likely to be maintained in mouse K16 as
the sequence identity between the orthologs is high
(McGowan, K., K. Hess, and P.A. Coulombe, unpublished
data, also see reference 43).
The multiple anomalies observed in the hair of the K16
replacement mice may indicate a role for keratins in hair
growth and follicle cycling. Hair follicles from K16 re-
placement mouse skin were consistently out of phase
compared with those from control mice (data not shown).
K16 replacement hairless skin featured large cysts
derived from pilosebaceous units and anomalies in
outer root sheath keratinocytes that likely preceded the
loss of hair. The treatment of hairless K16 replacement
skin with a depilating agent stimulated the regrowth
of hair. These observations suggest that progression
through the hair cycle is partially impaired in the K16,
and to a lesser extent, in the K16-C14 replacement mice.
A possible explanation for these changes may reside in
the outer root sheath where the transgene is expressed.
The transition from telogen to anagen is initiated when a
subpopulation of K14-expressing keratinocytes in the
bulge region of the outer root sheath is induced to mi-
grate down into the dermis when stimulated by a special-
ized group of fibroblasts, the dermal papillae (5). It may
be that in this context K16 affects the ability of these cells
to promote a timely progression through the stages of the
hair cycle.
Recently, a similar experiment was performed in which
the human simple epithelial type I keratin K18 was intro-
duced into the epidermis of K14 null mice (16). While K5
and K18 were able to form keratin filaments both in vitro
and in vivo, the resulting network was not strong enough
to withstand mechanical trauma and only partially com-
plemented the lethal phenotype (16). Paw skin, a body site
of constant mechanical friction, exhibited extensive skin
blistering in the K18 replacement mice. The cytoplasm of
the basal cells were devoid of keratin filaments and fea-
tured the presence of densely packed keratin aggregates,
which is reminiscent of dominant negative keratin mutants
in mice and in Dowling-Meara EBS patients (1, 63). In
contrast, no blistering was observed in back skin where the
majority of basal cells featured seemingly normal keratin
filament networks that were well distributed throughout
the cytoplasm and attached at desmosomes and hemides-
mosomes. However, when back skin was subjected to
acute mechanical trauma, the clumping and aggregation of
keratin filaments along with basal cell lysis and blistering
occurred (16). These data suggest that a K5/K18 filament
network can form in basal cells but that it is unable to
withstand normal mechanical stress and is susceptible to
blistering. These results provided evidence that epidermal
and simple epithelial type I keratins are not equivalent in
vivo. While this may have been predicted considering the
comparatively low sequence identity between K14 and
K18 (48%) (16), it contrasts sharply with the K16 replace-
ment mice results. These observations along with the K16
and K18 replacement mice will provide a context for ex-
amining the relationship between keratin filament organi-
zation and the susceptibility of keratinocytes to mechani-
cal trauma.
It has been proposed that the multiplicity of keratin se-
quences arose from successive gene duplication events
(10). Given their remarkably high sequence identity and
their proximity within the type I keratin gene cluster (11,
34, 52), it is highly probable that the genes for human K14,
K16, and K17 arose from a common ancestor. Our evi-
dence strongly argues that in addition to possessing dis-
tinct mechanisms of transcriptional regulation, the genes
for K14 and K16 have also evolved to provide a combina-
tion of shared and distinct functions at the protein level.
These conclusions may apply to the entire family of kera-
tin genes. Another large group of evolutionarily conserved
genes, the Hox family of transcription factors, are also or-
ganized in a tandem fashion with adjacent genes sharing
common functions (15, 20), suggesting that this may be a
general feature of large multigene families.
Context Dependent and Independent Effects of Human 
K16 in Mouse Skin
To date we have produced three different types of trans-
genic mice that express human K16 in skin. The tissue spe-
cific overexpression of human K16 (under the control ofPaladini and Coulombe K16 Partially Complements the K14 Null Phenotype 1199
its own promoter) led to widespread follicular keratosis in
the skin beginning one week after birth (8, 58). Aberrant
keratinization in the outer root sheath of hair follicles re-
sulted in the hyperproliferation and aberrant differentia-
tion of the adjacent inter-follicular epidermis. The appear-
ance of keratin filament aggregates near the nucleus and
cytoplasmic areas devoid of filaments in suprabasal kerati-
nocytes preceded the phenotypic changes observed in the
skin (40). In addition, cells were hypertrophic and there
were decreases in the number of desmosomes at the cell
surface that correlated with blister formation.
The ectopic expression of K16 directed to the basal
layer of the epidermis (using the K14 promoter) lead to a
phenotype consisting of scaly, wrinkled skin that lacked
fur (39). The epidermis was severely thickened and hair
follicle morphogenesis and hair production was delayed.
Basal cells were hypertrophic, hyperproliferative, and fea-
tured keratin filament aggregation. Cell-cell adhesion was
also drastically altered in the basal and suprabasal layers
of the epidermis. The phenotype improved beginning z5
wk after birth. These effects were very reminiscent of what
occurs when the EGF receptor signaling pathway is acti-
vated in skin.
In contrast to the other two mouse studies, K16 expres-
sion in basal keratinocytes lacking K14 (this study) did
not result in phenotypic epidermis at an early age. There
was no evidence of hyperproliferation or developmental
and morphological anomalies. It was not until after z5
weeks of age that the K16 replacement mice began to ex-
hibit alopecia and lesion formation. What becomes appar-
ent by comparing and contrasting these three different
transgenic mouse phenotypes is that the effect that K16
can have on a keratinocyte depends on many factors.
These include the location within the epidermis, the dif-
ferentiation status, and the keratin composition of the ke-
ratinocyte. The level to which it is expressed is also criti-
cal. The properties of K16 can be classified into context
dependent and independent effects. Independent of the
expression context, K16 has the ability to reorganize ker-
atin filaments and is able to perturb the normal develop-
ment and cycling of hair follicles when it is expressed in
the outer root sheath. Depending on the expression con-
text, K16 can affect cell size and cell-cell adhesion. It can
also affect proliferation, development, and differentiation
within the epidermis.
An exquisite example of the dramatic effects that the
expression context can have on K16 function is prolifera-
tion. A recent report has stated that K16 has the ability to
promote proliferation when transfected into a variety of
cultured epithelial cell lines (41). It further stated that K16
can antagonize the inhibitory effect that K10 has on prolif-
eration. Our results have provided a direct in vivo test of
the relevance of these claims. The presence of K16 in
progenitor basal cells of the epidermis (including kera-
tinocytes of the outer root sheath) can either have a
positive, negative, or neutral effect on keratinocyte prolif-
eration (39, this study). From these data, it appears that
the relationship between K16 expression and the control
of keratinocyte proliferation is complex and likely indi-
rect. This interpretation is consistent with the regulation of
K16 expression at the edges of skin wounds where the in-
duction of K16 protein does not correlate spatially or tem-
porally with enhanced proliferation in the epidermis
(30,  40).
Regulation of K16 Protein Expression
We generated four different transgenic mouse lines cover-
ing a wide range of copy numbers (see Materials and Meth-
ods) that expressed the human K16 cDNA in the basal
layer of the epidermis (39). K16 protein levels were differ-
ent in the four lines with the highest expressing lines hav-
ing three times as much K16 as the lowest expressing line.
The amount of K16 expressed in the highest expressing
lines was approximately equivalent to the amount of en-
dogenous mouse K14. Within each line, mice homozygous
for the transgene expressed approximately twice as much
transgene as mice heterozygous for the transgene. These
data suggested that basal keratinocytes have the ability to
accept a wide range of K16 protein. However, there ap-
peared to be an upper limit as two of the lines (with differ-
ent transgene copy numbers) expressed to approximately
equivalent levels (no. 6 and no. 21). It is likely that the lev-
els of the type II basal keratin K5, and possibly K6 (59),
determine the limit of transgene expression at the protein
level.
The amount of K16 expressed in the four lines varied
when bred into the K14 null background. However, there
was no variation within a replacement line as either the
heterozygous or homozygous genotype expressed equiva-
lent amounts of K16 protein. In fact, the amount of K16
transgene expressed in a heterozygous replacement mouse
was greater than the amount expressed in a heterozygous
ectopic mouse (within the same line). These facts clearly
indicate that the presence of K14 in basal cells strongly in-
fluences the amount of K16 protein that is present. Similar
results were also observed with the K16-C14 replacement
mice. One simple possibility that may explain these results
is that K16 does not effectively compete with endogenous
K14 and may turn over faster in basal cells of the epider-
mis and the outer root sheath. In fact, in the double re-
placement there was no evidence of competition or of one
keratin influencing the levels of the other. Considering the
structure of the two transgenes and the protein data, the
region responsible for this behavior lies somewhere be-
tween the head domain and the end of the rod domain of
K16. One potential biochemical determinant of this be-
havior may be the proline residue at position 188 (65).
While this proline does not appear to influence the solubil-
ity of human K16 in vivo, it may still affect its stability.
Despite the huge variation in K16 protein levels in the
ectopic mice, the amount of K14 protein remained con-
stant regardless of the transgene line and the genotype
(39). Even when K14 mRNA levels are increased due to
hyperproliferation (this study, reference 42) or decreased
twofold due to the targeted inactivation of the K14 allele
(K14 hemizygous null epidermis, reference 25), K14 pro-
tein levels remained unchanged. These data imply that de-
spite various genetic changes and biological contexts, the
level of K14 protein is tightly regulated in mouse epider-
mis and is not affected by the presence of K16. In addition,
in the absence of K14 protein, there is no mechanism that
increases the amount of K15 or other type I keratin pro-
teins in the epidermis to compensate for the absence ofThe Journal of Cell Biology, Volume 146, 1999 1200
K14 (25). This renders the K14 knockout distinct from the
targeted disruption of the genes for K4, K10, and K18 in
which there were major changes in other keratins at the
mRNA or protein level (27, 37, 42).
While K14 levels are tightly regulated, the amount of
K15 protein was dramatically reduced in the phenotypic
ectopic mice. This is consistent with a recent report stating
that the levels of human K15 mRNA are greatly reduced
in hyperproliferative epidermis (64). Surprisingly, in the
soluble pool of the replacement epidermis there was an in-
crease in the levels of K15 suggesting that there may be
competitive inhibition of its partitioning into the insoluble
pool by K16. Therefore, there may be multiple mecha-
nisms that limit K15 protein levels in the epidermis. Inter-
estingly, K5 protein levels in the K14 null mice were not as
dramatically reduced as might have been expected based
on the decreased amounts of type I proteins and the fact
that in cell culture studies, K5 protein is degraded in the
absence of K14 (3, 22, 24). In fact, in the phenotypic ec-
topic and the double replacement mice, the amount of K5
increased correlating with an increased amount of type I
keratins. These observations serve the underscore the
complexity of keratin regulation in the basal layer of the
epidermis.
In addition to the regulation of K16 at the protein level,
there also appear to be mechanisms that regulate it at the
level of the mRNA. While the amount of transgene pro-
tein doubled from the heterozygous ectopic to the ho-
mozygous ectopic mouse, the amount of mRNA did not.
In fact, the steady state mRNA levels in the homozygote
were much higher (greater than fourfold) than expected
compared with the heterozygote based on the protein
data. This may be partially accounted for by the increase
in the activity of the K14 promoter. Steady state levels of
K16 transgene mRNA levels also varied widely among the
different replacement lines despite the fact that the pro-
tein levels were similar. Cumulatively, these data suggest
that there is not a straightforward relationship between
the regulation of the K16 mRNA and the expression of the
protein. The various transgenic mice that we have gener-
ated may provide significant insight into the mechanisms
that regulate keratin expression at the level of both the
mRNA and the protein.
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